Last Update

This profile was last updated on 11/2/2017 and contains contributions from the  ZoomInfo Community.

is this you? Claim your profile.

Wrong Dolly Tyan?

Dolly B. Tyan

Professor of Pathology and Director

Stanford University

HQ Phone:  (650) 723-2300

Direct Phone: (650) ***-****direct phone

Email: d***@***.edu

Get Zoominfo Grow
Community Edition

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    the Plugin
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check Your Inbox to
    Sign Up for ZoomInfo Community Edition

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Stanford University

341 Galvez St

Stanford, California, 94305

United States

Company Description

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big ch...more

Find other employees at this company (47,711)

Web References(37 Total References)


Schedule and Program | 17th International HLA and Immunogenetics Workshop

Moderators: Dolly Tyan, Frans HJ Claas
Chia-Jung Chang and Dolly Tyan Dolly Tyan, Stanford University Dolly Tyan Dolly Tyan


Dolly Tyan : 17th International HLA and Immunogenetics Workshop

HOME > Steering Committee > Dolly Tyan
Dolly Tyan Dr. Dolly (Ness) Tyan is a Professor of Pathology and a Director of the Stanford University Histocompatibility, Immunogenetics & Disease Profiling Laboratory. She has been active in histocompatibility since 1972 and trained with Rose Payne and Carl Grumet. She served as President of the American Society for Histocompatibility and Immunogenetics in 2001, on the Board and various committees of UNOS, and the Histocompatibility committee of the NMDP. She is Chair of the national UNOS/OPTN Histocompatibility Committee. Her presentation to the UNOS Board was fundamental to the implementation of the virtual crossmatching policy now in place nationally. She was an invited member of the international consensus conference in May, 2012, on testing and clinical management associated with antibodies in transplantation. Her career has focused on antibody characterization as it relates to transplantation as well as definition of HLA and KIR genes. From her first publications on antibody production in vitro in the early 1970s and DR epitope definition using monoclonal antibodies in 1980, she has continued to define new serologic specificities. Most recently her studies have focused on the definition of clinically relevant HLA antibodies and their antigen/allele targets. Her specialty area of expertise is the use of IVIG to down regulate antibody production in highly sensitized patients and characterization of residual antibody for determination of optimal time to transplant or reversal of antibody mediated rejection. She is co-inventor of the IVIG therapy for treatment of highly HLA sensitized patients both before and after transplant and is also co-inventor of the C1q assay for determination of clinically relevant complement fixing HLA antibody using single antigen beads. She is deeply immersed in NGS for HLA genomic definition with a goal of defining the epitope targets of donor specific antibody. Her clinical responsibilities include directing a comprehensive histocompatibility laboratory of 55 FTEs servicing 9 different solid organ and bone marrow/stem cell transplant programs at Stanford. Dolly Tyan Dolly Tyan


Dolly Tyan : 17th International HLA and Immunogenetics Workshop

HOME > Steering Committee > Dolly Tyan
Dolly Tyan Dr. Dolly (Ness) Tyan is a Professor of Pathology and a Director of the Stanford University Histocompatibility, Immunogenetics & Disease Profiling Laboratory. She has been active in histocompatibility since 1972 and trained with Rose Payne and Carl Grumet. She served as President of the American Society for Histocompatibility and Immunogenetics in 2001, on the Board and various committees of UNOS, and the Histocompatibility committee of the NMDP. She is Chair of the national UNOS/OPTN Histocompatibility Committee. Her presentation to the UNOS Board was fundamental to the implementation of the virtual crossmatching policy now in place nationally. She was an invited member of the international consensus conference in May, 2012, on testing and clinical management associated with antibodies in transplantation. Her career has focused on antibody characterization as it relates to transplantation as well as definition of HLA and KIR genes. From her first publications on antibody production in vitro in the early 1970s and DR epitope definition using monoclonal antibodies in 1980, she has continued to define new serologic specificities. Most recently her studies have focused on the definition of clinically relevant HLA antibodies and their antigen/allele targets. Her specialty area of expertise is the use of IVIG to down regulate antibody production in highly sensitized patients and characterization of residual antibody for determination of optimal time to transplant or reversal of antibody mediated rejection. She is co-inventor of the IVIG therapy for treatment of highly HLA sensitized patients both before and after transplant and is also co-inventor of the C1q assay for determination of clinically relevant complement fixing HLA antibody using single antigen beads. She is deeply immersed in NGS for HLA genomic definition with a goal of defining the epitope targets of donor specific antibody. Her clinical responsibilities include directing a comprehensive histocompatibility laboratory of 55 FTEs servicing 9 different solid organ and bone marrow/stem cell transplant programs at Stanford. Dolly Tyan Dolly Tyan


http://www.kidney-friends.net/showthread.php?tid=2918&pid=24310#pid24310

It's was co-developed by Doctor Dolly Tyan, who now is with the Stanford School of Medicine, and directs the HLA-Immunogenetics and disease profiling lab.During dialysis treatments, patients are given blood containing a large mix of immunoglobulins, or antibodies, which attack each other, and actually bring down the number of organ rejecting antibodies."Therefore instead of being incompatible with 98 percent of the population, maybe they were incompatible with 40 percent," said Dr. Tyan.Dr. Tyan says of the 70,000 people in the U.S. waiting for a kidney donor, perhaps 20,000 could be crying those same tears of joy, but they aren't, partly because only five medical centers are trained to perform this therapy."What we're told is the doctors are very busy, they're not reading the medical journals, her doctors said they'd never heard of it," said Dr. Tyan.Dr Tyan hopes Joan's campaign leads to patients asking questions of their physicians."Okay, please tell me about my antibody profile.Do I have a lot or a little?Am I eligible for this kind of therapy?"said Dr. Tyan.


http://abclocal.go.com/kgo/story?section=news/health&id=6222285

It's was co-developed by Doctor Dolly Tyan, who now is with the Stanford School of Medicine, and directs the HLA-Immunogenetics and disease profiling lab.During dialysis treatments, patients are given blood containing a large mix of immunoglobulins, or antibodies, which attack each other, and actually bring down the number of organ rejecting antibodies."Therefore instead of being incompatible with 98 percent of the population, maybe they were incompatible with 40 percent," said Dr. Tyan.Dr. Tyan says of the 70,000 people in the U.S. waiting for a kidney donor, perhaps 20,000 could be crying those same tears of joy, but they aren't, partly because only five medical centers are trained to perform this therapy. "What we're told is the doctors are very busy, they're not reading the medical journals, her doctors said they'd never heard of it," said Dr. Tyan.Dr Tyan hopes Joan's campaign leads to patients asking questions of their physicians."Okay, please tell me about my antibody profile.Do I have a lot or a little?Am I eligible for this kind of therapy?"said Dr. Tyan.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory